Feb 2, 2021
Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel therapies for life-threatening acute respiratory and critical care conditions, announced today that it has successfully closed its seed funding round of $10 million. The offering was met with significant enthusiasm and exceeded the original target, attracting a wide range of experienced biopharmaceutical investors, including two funds that each contributed more than $3 million.
"We are very pleased to have accomplished this important milestone for the Company and to see investor confidence in ENA-001 as a treatment for patients experiencing life-threatening acute respiratory depression," stated Herm Cukier, Executive Chairman, President, and CEO of Enalare Therapeutics. "We are well-positioned to move forward with our plans to further capitalize the Company and achieve significant development milestones in the year ahead."
"This successful seed round is another validation of the potential for Enalare's novel drug compounds," stated Daniel Motto, Enalare's Chief Operating Officer. "We have already started to deploy these funds to grow our R&D organization, advance the clinical programs, and initiate advanced formulation work to expand our product offerings."
About Enalare Therapeutics Inc.
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical care conditions including respiratory depression caused by drug overdose, post-surgery, and pathogens such as COVID-19. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.
###
Contact:
Morgan Wagner
Investor Relations
[email protected]
Hackers made off with around $6 billion in digital currency in what could be the biggest crypto heist in history. Binance said it will cover the losses.
A war room. A global conference call. A founder who live-posted about the largest crypto heist in history. Inside a frantic 24 hours at the world’s biggest crypto exchange.
The defamation suit focused on an article about a birthday note to Jeffrey Epstein. It was the president’s second attempt to claim the publication had acted with actual malice.
Big law firms, legal tech vendors, and in-house legal departments at companies like Microsoft and Nvidia are all hiring legal engineers, a new position for lawyers with A.I. skills.
After chicken, consumers are buying more beef, while pork, turkey and soy products remain flat.
More horses from overseas are competing in America’s marquee events, as the sport enjoys a renaissance.
Experts point to well-publicized turmoil at the government agency last year as a potential spark.
The 20th Central Committee of the Communist Party of China convened its fifth plenary session in Beijing from October 26 to 29, 2026, where it deliberated and adopted the Resolution of the Central Committee of the Communist Party of China on Certain Major Issues concerning Persevering with Full and Rigorous Party Self-Governance.
70 years on, why global buyers keep coming back to Canton Fair
China's purchasing managers' index for the manufacturing sector came in at 49.3 in October, down 0.8 percentage points from the previous month, while the non-manufacturing PMI stood at 49.7, down 0.5 percentage points.
In Malaysia, U.S. and Chinese tech giants are pouring billions into vast data centers, straining local resources and testing the limits of Washington’s restrictions on advanced chips.
The looming departure of the European Central Bank’s president, Christine Lagarde, has set in motion a high-stakes search for her successor.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.